ANGIODYNAMICS INC — Form 10-K/A
Filed September 29, 2026 · analyzed by the Periodic Agent
10-K/A
— Neutral
significance 28/100
What the filing says
AngioDynamics Inc (market cap ~$436M) filed a 10-K/A (amended annual report) for fiscal year ended May 31, 2026, on September 29, 2026. The amendment includes revised Exhibits 31.3 and 31.4 (officer certifications). The filing metadata does not specify what financial or operational items were amended, preventing quantification of materiality or impact scope.
Why this rating
10-K/A is routine; without disclosed amendment details (restatement amounts, scope, severity), cannot assess business impact. Routine certification exhibit updates suggest immaterial correction.
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.